医药生物技术领域联合推广行销（2014-2024）

本报告深入了解并分析了公司如何以及为何进行联合促销和联合行销交易。

这份经过全面修订的报告提供了2014年至2024年联合促销和联合行销交易的详细资讯。

本报告提供了双方宣布的联合促销和联合行销协议的付款条款。这些资料提供了有关支付条款和其他交易条款的有用见解。

了解潜在合作伙伴谈判条款和条件的灵活性以及条款谈判期间的预期内容可以为谈判过程提供重要的见解。许多小型企业会要求提供有关付款条件的详细信息，但在触发付款以及如何转让权利时，细节是关键。

本报告提供了当前协议交易和合作伙伴资料库中记录的自2014年以来宣布的联合促销和联合营销交易的完整列表，以及可用的财务条款，以及提供的线上链接合作伙伴向美国证券交易委员会提交的实际联合推广/联合行销协议文件的副本。

主要优点

本报告为读者提供了以下主要好处：

• 了解2014年以来的交易完成趋势
• 查看联合促销和联合行销交易
• 基准分析：确定交易的市场价值
• 财务状况
• 交易清单：依公司名称（A-Z）、依治疗领域、依技术类型
• 主要交易（金额基础）
• 最活跃的交易撮合者
• 每笔交易的资产识别和交易条件
• 取得合约文件：深入了解交易结构
• 实质审查：评估拟议交易条款对合作伙伴公司的适用性
• 节省数百小时的研究时间

调查范围

• 本报告目的是详细了解全球领先的生物製药公司之间的共同推广和联合行销趋势以及交易结构。

此报告中的交易包括：

• 生物製药产业联合促销与联合行销交易的趋势
• 联合促销/联合行销交易架构：概述
• 製药和生物技术行业的联合促销和联合行销交易记录列表
• 主要联合促销与联合行销交易（价值基础）
• 最活跃的共同促销/联合行销交易促成者
• 共同推广与共同行销的主要合作伙伴资源

此报告列出了可获得资讯的交易：

• 依公司名称（A-Z）
• 按交易金额
• 依治疗领域
• 依技术型
• 每个交易标题都透过网路连结连结到实际交易记录的线上版本。
• 此报告提供了对许可协议的可用合约文件的全面存取。

透过分析合约协议，实质审查可以：

• 授予和选择了哪些权利？
• 合约授予了哪些权利？
• 授予哪些专有权？
• 合约的付款结构是怎样的？
• 如何审核销售和付款？
• 合约期限是多久？
• 合约的主要条款是如何定义的？
• 如何对待和拥有知识产权？
• 谁负责商业化？
• 谁负责开发、供应和製造？
• 如何管理保密和发布？
• 如何解决争议？
• 什么情况下可以取消合约？
• 如果所有者发生变化会怎样？
• 已就何种类型的分授权或分包条款达成协议？
• 公司需要哪些样板条款？
• 哪些样板条款会根据合作伙伴和交易类型的不同而有所不同？
• 每家公司都主张合约法中的哪一个管辖权？

目录

执行摘要

第1章 简介

第2章 联合促销与联合行销交易趋势

• 简介
• 联合促销/联合行销协议的定义
• 联合促销和联合行销协议的趋势（自2014年以来）
  • 达成联合促销/行销交易：依年份（2014-2024年）
  • 达成联合促销/行销交易：依发展阶段：依2014-2024年）
  • 达成联合促销/行销交易：依行业分类（2014-2024年）
  • 达成联合促销/行销交易：依治疗领域：依2014-2024年）
  • 达成联合促销/行销交易：依技术类型：依2014-2024年）
  • 达成联合促销/行销交易：针对最活跃的公司（2014-2024年）
• 签订联合促销/联合行销协议的原因
• 未来联合促销/联合行销协议

第3章 联合促销与联合行销交易架构：概述

• 简介
• 联合促销/联合行销协议的架构

第4章 重大联合促销及联合行销交易

• 简介
• 主要联合促销与联合行销交易（价值基础）

第5章 最活跃的联合促销/联合行销交易撮合者前 25 名

• 简介
• 前 25 位最活跃的联合促销/联合行销交易撮合者

第6章 联合促销/联合行销协议清单（包括合约细节）

• 简介
• 联合促销与联合行销交易协议（2014-2024年）
• 交易列表
• 交易清单：联合促销/联合行销协议，依公司名称（A-Z）
• 交易清单：联合促销/联合行销协议，依治疗领域
• 交易清单：联合促销/联合行销协议，依技术类型
• 关于Biopharma Research Ltd
• 目前的合作关係
• 当前合约
• 最近发布的Current Partnering报告标题

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter co-promotion and co-marketing deals.

Fully revised and updated, the report provides details of co-promotion and co-marketing deals from 2014 to 2024.

The report provides access to co-promotion and co-marketing deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of co-promotion and co-marketing deals announced since 2014 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of co-promotion and co-marketing dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in co-promotion and co-marketing as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of co-promotion and co-marketing deals.

Chapter 4 provides a review of the leading co-promotion and co-marketing deals since 2014. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active co-promotion and co-marketing dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of co-promotion and co-marketing deals organized by company A-Z, therapy, technology and industry type signed and announced since 2014 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the co-promotion and co-marketing deal.

The deal directory includes a comprehensive listing of all co-promotion and co-marketing deals announced since 2014. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in co-promotion and co-marketing dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about co-promotion and co-marketing alliances.

Key benefits

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2014
• Browse co-promotion and co-marketing deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the co-promotion and co-marketing trends and structure of deals entered into by leading biopharma companies worldwide.

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology includes:

• Trends in co-promotion and co-marketing dealmaking in the biopharma industry
• Overview of co-promotion and co-marketing deal structure
• Directory of co-promotion and co-marketing deal records covering pharmaceutical and biotechnology
• The leading co-promotion and co-marketing deals by value
• Most active co-promotion and co-marketing dealmakers
• The leading co-promotion and co-marketing partnering resources

In Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for co-promotion and co-marketing deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in co-promotion and co-marketing dealmaking

• 2.1. Introduction
• 2.2. Definition of co-promotion and co-marketing deals
• 2.3. Trends in co-promotion and co-marketing deals since 2014
  • 2.3.1. Co-promotion and co-marketing dealmaking by year, 2014-2024
  • 2.3.2. Co-promotion and co-marketing dealmaking by phase of development, 2014-2024
  • 2.3.3. Co-promotion and co-marketing dealmaking by industry sector, 2014-2024
  • 2.3.4. Co-promotion and co-marketing dealmaking by therapy area, 2014-2024
  • 2.3.5. Co-promotion and co-marketing dealmaking by technology type, 2014-2024
  • 2.3.6. Co-promotion and co-marketing dealmaking by most active company, 2014-2024
• 2.4. Reasons for entering into co-promotion and co-marketing partnering deals
• 2.5. The future of co-promotion and co-marketing deals

Chapter 3 - Overview of co-promotion and co-marketing deal structure

• 3.1. Introduction
• 3.2. Co-promotion and co-marketing agreement structure

Chapter 4 - Leading co-promotion and co-marketing deals

• 4.1. Introduction
• 4.2. Top co-promotion and co-marketing deals by value

Chapter 5 - Top 25 most active co-promotion and co-marketing dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active co-promotion and co-marketing dealmakers

Chapter 6 - Co-promotion and co-marketing deals including contracts directory

• 6.1. Introduction
• 6.2. Co-promotion and co-marketing deals with contracts 2014-2024
• Deal directory
• Deal directory - Co-promotion and co-marketing dealmaking by companies A-Z
• Deal directory - Co-promotion and co-marketing dealmaking by therapy area
• Deal directory - Co-promotion and co-marketing dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of co-promotion and co-marketing
• Figure 2: Trends in co-promotion and co-marketing deal announcements, 2014-2024
• Figure 3: Co-promotion and co-marketing deals signed at each phase of development, 2014-2024
• Figure 4: Co-promotion and co-marketing deals by industry sector, 2014-2024
• Figure 5: Co-promotion and co-marketing deals by therapy area, 2014-2024
• Figure 6: Co-promotion and co-marketing deals by technology type, 2014-2024
• Figure 7: Top 25 most active co-promotion and co-marketing dealmakers, 2014-2024
• Figure 8: Top co-promotion and co-marketing deals by value, 2014-2024
• Figure 9: Most active co-promotion and co-marketing dealmakers, 2014-2024